,,ii  #aafth ,,congress  #b;d ,session  
,s4 #cide  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #aa1     
#bjbj,mrs4 ,loeffler 7for herself1 ,ms4 
,ernst1 and ,mr4 ,cruz7 introduced the  
following bill2 which was read twice and
 referred to the ,committee on ,finance 
,a ,,bill  ,to amend the ,internal      
,revenue ,code of #aihf to provide      
incentives for relocating manufacturing 
of pharmaceuticals and medical supplies 
and devices to the ,united ,states4  #a4
 ,short title ,this ,act may be cited as
 the ,bring ,entrepreneurial            
,advancements ,to ,consumers ,here ,in  
,north ,america ,act4  #b4 ,findings    
,congress finds as follows3 7#a7 ,in    
late ,december #bjai1 authorities in the
 city of ,wuhan in ,china's ,hubei      
,province reported a cluster of         
pneumonia cases of unknown cause4  7#b7 
,the ,government of the ,people's       
,republic of ,china eventually          
identified the cause of the outbreak to 
be a novel coronavirus that would later 

be understood to cause a respiratory    
illness in humans1 known as ,,covid-#ai4
  7#c7 ,the pandemic spread of          
,,covid-#ai and the geographic location 
of its origin caused reverberations in  
medical supply chains that reached      
around the world4  7#d7 ,the ,,covid-#ai
 pandemic highlights the ,united ,states
 dependency on ,china for critical      
medical supplies and pharmaceutical     
products4  7#e7 ,the ,government of the 
,people's ,republic of ,china and the   
,chinese ,communist ,party prioritize   
state support for biotechnology         
manufacturing as a strategic industry   
under the ,made in ,china #bjbe         
initiative4  7#f7 ,according to the     
,united ,states ,food and ,drug         
,administration1 as of #bjah1 ,china is 
the largest exporter of medical devices 
and the second largest exporter of drugs
 and biologics to the ,united ,states4  
7#g7 ,chinese pharmaceutical companies  
produce more than #ij percent of the    
supply of antibiotics1 vitamin ,c1      

ibuprofen1 and hydrocortisone in the    
,united ,states4  7#h7 ,in ,march #bjbj1
 ,xinhua ,news ,service1 a ,chinese     
state-controlled news agency1 reprinted 
an article insinuating that if ,china   
were to announce its strategic control  
of medical products and ban exports to  
the ,united ,states1 the ,united ,states
 would be plunged into the vast ocean of
 novel coronavirus4  7#i7 ,the ability  
of the ,government of the ,people's     
,republic of ,china and the ,chinese    
,communist ,party to control the medical
 supply chain poses a risk to the       
national security of the ,united        
,states4  7#aj7 ,companies should be    
incentivized through a competitive tax  
structure to manufacture and produce    
pharmaceuticals and medical devices in  
the ,united ,states4  #c4 ,tax          
incentives for relocating manufacturing 
of pharmaceuticals and medical supplies 
and devices to the ,united ,states  7a7 
,accelerated depreciation for           
nonresidential real property ,section   

#afh of the ,internal ,revenue ,code of 
#aihf is amended by adding at the end   
the following new subsection3  7n7      
,accelerated depreciation for           
nonresidential real property acquired in
 connection with the relocation of      
manufacturing of pharmaceuticals and    
medical supplies and devices to the     
,united ,states  7#a7 ,treatment as     
#bj-year property ,for purposes of this 
section1 qualified nonresidential real  
property shall be treated as #bj-year   
property4  7#b7 ,application of bonus   
depreciation ,for application of bonus  
depreciation to qualified nonresidential
 real property1 see subsection 7k74     
7#c7 ,qualified nonresidential real     
property ,for purposes of this          
subsection1 the term qualified          
nonresidential real property means      
nonresidential real property placed in  
service in the ,united ,states by a     
qualified manufacturer if such property 
is acquired by such qualified           
manufacturer in connection with a       

qualified relocation of manufacturing4  
7#d7 ,qualified manufacturer ,for       
purposes of this subsection1 the term   
qualified manufacturer means any person 
engaged in the trade or business of     
manufacturing a qualified medical       
product4  7#e7 ,qualified medical       
product ,for purposes of this           
subsection1 the term qualified medical  
product means any pharmaceutical1       
medical device1 or medical supply4  7#f7
 ,qualified relocation of manufacturing 
,for purposes of this subsection-- 7,a7 
,in general ,the term qualified         
relocation of manufacturing means1 with 
respect to any qualified manufacturer1  
the relocation of the manufacturing of a
 qualified medical product from a       
foreign country to the ,united ,states4 
7,b7 ,relocation of property not        
required ,for purposes of subparagraph  
7,a71 manufacturing shall not fail to be
 treated as relocated merely because    
property used in such manufacturing was 
not relocated4  7,c7 ,relocation of not 

less than equivalent productive capacity
 required ,for purposes of subparagraph 
7,a71 manufacturing shall not be treated
 as relocated unless the property       
manufactured in the ,united ,states is  
substantially identical to the property 
previously manufactured in a foreign    
country and the increase in the units of
 production of such property in the     
,united ,states by the qualified        
manufacturer is not less than the       
reduction in the units of production of 
such property in such foreign country by
 such qualified manufacturer4  7#g7     
,application to possessions of the      
,united ,states ,for purposes of this   
subsection1 the term ,united ,states    
includes any possession of the ,united  
,states4  4  7b7 ,exclusion of gain on  
disposition of property in connection   
with qualified relocation of            
manufacturing  7#a7 ,in general ,part   
,,iii of subchapter ,b of chapter #a of 
such ,code is amended by inserting after
 section #aci;,h the following new      

section3  #aci;,i4 ,exclusion of gain on
 disposition of property in connection  
with qualified relocation of            
manufacturing  7a7 ,in general ,in the  
case of a qualified manufacturer1 gross 
income shall not include gain from the  
sale or exchange of qualified relocation
 disposition property4  7b7 ,qualified  
relocation disposition property ,for    
purposes of this section1 the term      
qualified relocation disposition        
property means any property which-- 7#a7
 is sold or exchanged by a qualified    
manufacturer in connection with a       
qualified relocation of manufacturing1  
and  7#b7 was used by such qualified    
manufacturer in the trade or business of
 manufacturing a qualified medical      
product in the foreign country from     
which such manufacturing is being       
relocated4  7c7 ,other terms ,terms used
 in this section which are also used in 
subsection 7n7 of section #afh shall    
have the same meaning when used in this 
section as when used in such subsection4

  4  7#b7 ,clerical amendment ,the table
 of sections for part ,,iii of          
subchapter ,b of chapter #a of such     
,code is amended by inserting after the 
item relating to section #aci;,h the    
following new item3  ,sec4 #aci;,i4     
,exclusion of gain on disposition of    
property in connection with qualified   
relocation of manufacturing4  4  7c7    
,effective dates  7#a7 ,accelerated     
depreciation ,the amendment made by     
subsection 7a7 shall apply to property  
placed in service after the date of the 
enactment of this ,act4  7#b7 ,exclusion
 of gain ,the amendments made by        
subsection 7b7 shall apply to sales and 
exchanges after the date of the         
enactment of this ,act4